(Q44337560)

2 December 2017

title

Humoral immunity and atherosclerosis (English)

1 reference

2 December 2017

1 reference

Gabriel Virella

1

1 reference

2 December 2017

Maria F Lopes-Virella

series ordinal

2

1 reference

2 December 2017

language of work or name

English

0 references

publication date

1 March 2003

1 reference

2 December 2017

1 reference

2 December 2017

volume

9

1 reference

2 December 2017

issue

3

1 reference

2 December 2017

page(s)

243-4; author reply 244-5

1 reference

https://scigraph.springernature.com/pub.10.1038/nm0303-243

2 December 2017

exact match

0 references

cites work

Innate and acquired immunity in atherogenesis

1 reference

https://api.crossref.org/works/10.1038%2FNM0303-243

7 January 2021

Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis

1 reference

https://api.crossref.org/works/10.1038%2FNM0303-243

7 January 2021

Hyperimmunization of apo-E-deficient mice with homologous malondialdehyde low-density lipoprotein suppresses early atherogenesis

1 reference

https://api.crossref.org/works/10.1038%2FNM0303-243

7 January 2021

Effect of immunization with homologous LDL and oxidized LDL on early atherosclerosis in hypercholesterolemic rabbits

1 reference

https://api.crossref.org/works/10.1038%2FNM0303-243

7 January 2021

Human-derived anti-oxidized LDL autoantibody blocks uptake of oxidized LDL by macrophages and localizes to atherosclerotic lesions in vivo

1 reference

https://api.crossref.org/works/10.1038%2FNM0303-243

7 January 2021

Immunization of LDL receptor-deficient mice with homologous malondialdehyde-modified and native LDL reduces progression of atherosclerosis by mechanisms other than induction of high titers of antibodies to oxidative neoepitopes

1 reference

https://api.crossref.org/works/10.1038%2FNM0303-243

7 January 2021

Immunochemical characterization of purified human oxidized low-density lipoprotein antibodies

1 reference

https://api.crossref.org/works/10.1038%2FNM0303-243

7 January 2021

Antibodies to oxidized LDL and LDL-containing immune complexes as risk factors for coronary artery disease in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FNM0303-243

7 January 2021

Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man

1 reference

https://api.crossref.org/works/10.1038%2FNM0303-243

7 January 2021

Proatherogenic and proinflammatory properties of immune complexes prepared with purified human oxLDL antibodies and human oxLDL.

1 reference

https://api.crossref.org/works/10.1038%2FNM0303-243

7 January 2021

LDL immunization induces T-cell-dependent antibody formation and protection against atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNM0303-243

7 January 2021

Lipoprotein-antibody immune complexes. Their catabolism and role in foam cell formation

1 reference

https://api.crossref.org/works/10.1038%2FNM0303-243

7 January 2021

Nonenzymatic glucosylation of low-density lipoprotein alters its biologic activity

1 reference

https://api.crossref.org/works/10.1038%2FNM0303-243

7 January 2021

Autoantibodies to glucosylated proteins in the plasma of patients with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FNM0303-243

7 January 2021

Antibodies to oxidized LDL in relation to intima-media thickness in carotid and femoral arteries in 58-year-old subjectively clinically healthy men.

1 reference

https://api.crossref.org/works/10.1038%2FNM0303-243

7 January 2021

Autoantibodies against oxidized low-density lipoprotein and cardiolipin in patients with coronary heart disease

1 reference

https://api.crossref.org/works/10.1038%2FNM0303-243

7 January 2021

Temporal increases in plasma markers of oxidized low-density lipoprotein strongly reflect the presence of acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1038%2FNM0303-243

7 January 2021

B-lymphocyte deficiency increases atherosclerosis in LDL receptor-null mice

1 reference

https://api.crossref.org/works/10.1038%2FNM0303-243

7 January 2021

Protective immunity against atherosclerosis carried by B cells of hypercholesterolemic mice

1 reference

https://api.crossref.org/works/10.1038%2FNM0303-243

7 January 2021

Identifiers

DOI

10.1038/NM0303-243

1 reference

2 December 2017

1 reference